The systematic review and meta-analysis by Carvalho et al. underscore that relevant moderators/confounders (e.g., BMI, depression severity, and type of assay) should be controlled for when considering the role of leptin as putative MDD diagnostic biomarker [53]. Here, LEP is linked to depressive symptom measurement.